Unstable angina and non-ST-segment elevation myocardial infarction: perspectives on combination therapy
R P Villareal1, P Kim, J J Ferguson
1Section of Adult Cardiology, Texas Heart Institute and St Luke's Episcopal Hospital, Houston 77030, USA.
Texas Heart Institute Journal
|January 5, 2002
Summary
Combination therapies targeting platelet function, coagulation, and lesions significantly reduce risks for unstable angina and myocardial infarction patients. These treatments offer improved outcomes by preventing death and ischemic complications.
Area of Science:
- Cardiology
- Vascular Medicine
- Pharmacology
Background:
- Unstable angina and non-ST segment elevation myocardial infarction are critical cardiovascular conditions.
- Effective management is crucial to prevent adverse outcomes like death and ischemic events.
Purpose of the Study:
- To provide an overview of current treatment options for healthcare providers.
- To highlight the role of new and combination therapies in managing these conditions.
Main Methods:
- Review of recent clinical data and trials.
- Focus on combination therapies targeting multiple pathways of thrombotic progression.
Main Results:
- Combination therapies targeting platelet function (aspirin, thienopyridines, GP IIb/IIIa antagonists) show efficacy.
- Agents targeting the coagulation cascade (heparin, low-molecular-weight heparin) are effective.
- Percutaneous intervention addresses the physical characteristics of the lesion.
Conclusions:
- Combination therapies targeting platelet aggregation, coagulation, and lesion intervention reduce the risk of death and ischemic complications.
- Evidence supports the use of multi-targeted approaches for managing acute coronary syndromes.
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:27Angina II: Classification
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:20Angina V: Nursing Management
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...